Refined CYP2E1
CYP2E1-mediated metabolism
Fused-grid template
Regioselective reaction
Journal
Drug metabolism and pharmacokinetics
ISSN: 1880-0920
Titre abrégé: Drug Metab Pharmacokinet
Pays: England
ID NLM: 101164773
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
received:
28
02
2021
revised:
16
05
2021
accepted:
23
06
2021
pubmed:
22
10
2021
medline:
14
1
2022
entrez:
21
10
2021
Statut:
ppublish
Résumé
A Template system for a prediction of human CYP2E1-mediated reactions (Drug Metab Rev 2011) has been refined with the introduction of ideas of Trigger-residue and the residue-initiated movement of ligands in the active site. The refined system also includes ideas of bi-molecule binding and angled-placement, which allow to sit diverse types of ligands on Template. With the use of these ideas in common with other Template systems for human CYP1A1, CYP1A2 and CYP3A4 (Drug Metab Pharmacokinet 2016, 2017, 2019, and 2020), 349 reactions of 192 distinct chemicals published as CYP2E1 ligands were examined in the refined system. Verifications of good and poor substrates, regioselectivity and also inhibitory interaction were available faithfully for these ligands from their placements on the refined Template and rules for interaction modes, accompanied with their deciphering information to lead to the judgements. The refined CYP2E1 Template system will thus offer more reliable estimations of human CYP2E1 catalysis toward ligands of diverse structures.
Identifiants
pubmed: 34673327
pii: S1347-4367(21)00034-3
doi: 10.1016/j.dmpk.2021.100413
pii:
doi:
Substances chimiques
Ligands
0
Cytochrome P-450 CYP2E1
EC 1.14.13.-
Cytochrome P-450 CYP1A1
EC 1.14.14.1
Cytochrome P-450 CYP1A2
EC 1.14.14.1
Cytochrome P-450 CYP3A
EC 1.14.14.1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
100413Informations de copyright
Copyright © 2021 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare no conflict of interest.